Skip to content
Clinical Trials – home

Cefuroxime: A Comprehensive Guide for Patients

7 / 9
trials open to patients / all trials
8+
Countries

In short

This article explores the use of cefuroxime, a second-generation cephalosporin antibiotic, in various clinical trials. Cefuroxime is being studied for its effectiveness in preventing and treating infections across different medical scenarios, including post-surgical infections, pregnancy-related conditions, and pediatric care. The trials aim to optimize dosing regimens, compare administration methods, and assess safety profiles in diverse patient populations.

What is Cefuroxime?

Cefuroxime is an antibiotic medication used to treat various bacterial infections. It belongs to a class of antibiotics called cephalosporins. Cefuroxime works by killing bacteria or preventing their growth. This medication is also known by other names, including:

  • Cefuroxime axetil (oral form)
  • Ceftin (brand name)
  • Cefuroxime sodium (intravenous form)

Uses of Cefuroxime

Cefuroxime is used to treat a wide range of bacterial infections, including:

  • Urinary tract infections (UTIs): Cefuroxime is effective in treating and preventing UTIs, especially in pregnant women.
  • Respiratory tract infections: It can be used to treat infections of the lungs and airways.
  • Skin and soft tissue infections: Cefuroxime is effective against various skin infections.
  • Surgical site infections: It is commonly used as a preventive measure before and after surgery to reduce the risk of infections.
  • Lyme disease: Cefuroxime axetil is used to treat early Lyme disease, particularly the skin rash known as erythema migrans.

How Cefuroxime is Administered

Cefuroxime can be administered in several ways, depending on the type of infection and the patient's condition:

  • Oral tablets: Cefuroxime axetil is available as oral tablets, typically taken twice daily for a prescribed period.
  • Intravenous (IV) injection: For more severe infections or in hospital settings, cefuroxime may be given as an IV injection.
  • Prophylactic use: Before surgery, cefuroxime is often given as a single dose to prevent infections. The timing and dosage may vary depending on the procedure and patient factors.

Effectiveness of Cefuroxime

Cefuroxime has been shown to be effective in treating various bacterial infections. Some key points about its effectiveness include:

  • In treating urinary tract infections during pregnancy, cefuroxime has been found to reduce the rate of bacteriuria (bacteria in urine) and related complications.
  • For surgical prophylaxis, cefuroxime is effective in reducing the risk of post-operative infections when administered before or during surgery.
  • In treating early Lyme disease, cefuroxime axetil has shown comparable effectiveness to doxycycline, another commonly used antibiotic.

Cefuroxime in Special Populations

Cefuroxime is used in various patient populations, including:

  • Pregnant women: Cefuroxime is considered safe for use during pregnancy and is often used to treat and prevent urinary tract infections in pregnant women.
  • Newborns and infants: Research is ongoing to determine the appropriate dosing and safety of cefuroxime in neonates and young infants.
  • Surgical patients: Cefuroxime is commonly used as a preventive antibiotic in various surgical procedures, including cardiac surgery and caesarean sections.

Side Effects and Safety

Like all medications, cefuroxime can cause side effects. Common side effects may include:

  • Nausea and vomiting
  • Diarrhea
  • Skin rash
  • Headache

In rare cases, more serious side effects can occur. It's important to discuss potential side effects with your healthcare provider. Additionally, cefuroxime may interact with other medications, so inform your doctor about all medications you are taking.

Ongoing Research

Several clinical trials are currently investigating various aspects of cefuroxime use, including:

  • Optimal dosing strategies for surgical prophylaxis.
  • Effectiveness in treating specific infections, such as pyelonephritis (kidney infection) in pregnancy.
  • Use in combination with other antibiotics for enhanced effectiveness.
  • Impact on gut microbiota in newborns when used for caesarean section prophylaxis.

These ongoing studies aim to improve our understanding of cefuroxime's effectiveness, safety, and optimal use in various clinical scenarios.

Questions people often ask

Conditions where Cefuroxime is being studied

Each condition opens its own overview and trial list

Trials with Cefuroxime

Recruiting trials first

See all 9 →
Quick filters
  • Participants:Adults
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).